tm
Seeing Is Believing
tm
Seeing Is Believing
ABOS is currently covered by 2 analysts with an average price target of $7.25. This is a potential upside of $6.17 (223.66%) from yesterday's end of day stock price of $2.24.
Acumen Pharmaceuticals's activity chart (see below) currently has 33 price targets and 40 ratings on display. The stock rating distribution of ABOS is 100% BUY.
Highest price target for ABOS is $8, Lowest price target is $5, average price target is $7.25.
Most recent stock forecast was given by THOMAS SHRADER from BTIG on 16-Sep-2026. First documented stock forecast 26-Jul-2021.
Currently out of the existing stock ratings of ABOS, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Jul-2022
$8
$5.76 (257.14%)
$8
12 days ago
(16-Sep-2026)
0/8 (0%)
$5.39 (206.51%)
Buy Since 22-Jan-2022
$5
$2.76 (123.21%)
$8
13 days ago
(15-Sep-2026)
0/5 (0%)
$2.11 (73.01%)
Buy Since 30-Jun-2022
$11
$8.76 (391.07%)
1 years 6 months ago
(28-Mar-2025)
0/8 (0%)
$9.81 (824.37%)
Buy Since 26-Jul-2021
$4
$1.76 (78.57%)
1 years 6 months ago
(28-Mar-2025)
0/4 (0%)
$2.81 (236.13%)
Buy Since 08-Mar-2022
$10
$7.76 (346.43%)
$17
1 years 11 months 24 days ago
(04-Oct-2024)
0/2 (0%)
$7.63 (321.94%)
Which analyst most recently updated their price target on ABOS (Acumen Pharmaceuticals)?
Which analyst has the most public recommendations on ABOS (Acumen Pharmaceuticals)?
Which analyst is the currently most bullish on ABOS (Acumen Pharmaceuticals)?
Which analyst is the currently most reserved on ABOS (Acumen Pharmaceuticals)?
